Telepsychiatry In Dialysis Patients: A Dream Or A Reality?

Name: Telepsychiatry In Dialysis Patients: A Dream Or A Reality?
Start: 2021-05-11T18:00:00-04:00
End: 2021-05-11T19:00:00-04:00

Webinar May 11 6:00 pm to 7:00 pm EST

Telepsychiatry In Dialysis Patients: A Dream Or A Reality?

Depression is the most common mental health illness in patients with kidney failure. The reported prevalence of depression in the dialysis population varies widely and can be as high as approximately 40%.¹ Join us for a conversation with Dr Shirazian and Dr Behrens as we explore the utility of telepsychiatry in patients undergoing hemodialysis, potential barriers, and the importance of addressing mental health in patients with chronic kidney disease.

Please note: Due to high levels of interest, please access this webinar via your computer.

Reference

¹King-Wing Ma T, Kam-Tao Li P. Depression in dialysis patients. Nephrology. 2016 Aug;21(8):639-46.

*Drs Shayan Shirazian and Jake Behrens are paid consultants of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Dr Tazin Aijaz is an employee of OPDC.

Shirazian Shayan, MD

Assistant Professor of Medicine, Division of Nephrology
Jake Behrens, MD

CEO & Medical Director, Regional Director Envision ADHD, Brightside Health
Aijaz Tazin, PharmD, BCPS

Nephrology Senior Medical Science Liaison Otsuka Pharmaceutical Development & Commercialization, Inc.*